The number of reported COVID cases in our region has decreased over the last week and there are declines in hospital presentations and residential aged care facility outbreaks. General practices should take the necessary steps to ensure they are able to respond to this increase. Infection control and wearing masks (staff and patients) is still critically important.
This antiviral pre-assessment form is to support timely and safe access to antiviral medicines for adults who are at higher risk of severe disease.
The form should be completed by a doctor (preferably the person’s regular GP) in consultation with the person or the person’s guardian, before the person tests positive for influenza or COVID-19.
For people at higher risk of severe disease the GP should discuss what test should be done if they get sick (this might include having a prepared pathology form).
The pre-assessment form does not replace the requirement for a doctor to assess the person and prescribe the medication prior to administration.
Change to notification advice for COVID antiviral treatment pathways
Healthdirect notifies the consumer via text message to call their GP if they may be potentially eligible for antivirals, and also has notified their GP or GPRC by secure messaging of the patient status.
This secure message to GPs and GPRCs was followed up with a phone call. In response to feedback from GPs, and due to the successful implementation of secure messaging for this program, the follow up call is no longer needed and has ceased from 1 January 2023.
CESPHN Vax at Home service
The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and from Local Health Districts. Patient self-referrals will not be accepted.
All referrals must be sent through this Vax at Home Service Online Form. Please also indicate if an influenza vaccine is also required. Please note, a referral will need to be attached to the online form. For further information on the program, please contact us. This service will continue to receive referrals over the Christmas shut down period. Please note if your referral is urgent service will prioritise accordingly and vaccinations arranged.
Pulse oximeters for your patients
CESPHN is still providing pulse oximeters – please see details below
Individual patients – we have access to a small supply of oximeters. GPs with patients they believe require a pulse oximeter urgently are asked to complete this CESPHN Pulse Oximeter online form with the patients details and we will arrange delivery of an oximeter
Sites participating in the COVID-19 Vaccine Program can log into CVAS and directly request to activate, reactivate or deactivate access to one or more vaccine products.
Withdrawing from specific vaccines:
Before making a request to deactivate a vaccine type, sites will need to ensure they have completed a final Stock Management Report and recorded zero stock on hand for the vaccine type they are requesting to be deactivated for. Please note, a request does not guarantee a site will be activated for the requested vaccine type, approval of requests is at the discretion of the Department.
Withdrawing from the program completely:
If a site would like to withdraw completely from the program, they will need to log into CVAS to request withdrawal from all vaccine types and then contact their local PHN to fully withdraw from the program.
For your site to withdraw from the program, practices must:
Have completed a final stock management report and recorded zero stock on hand for all vaccine types they have on hand.
Sites can remain deactivated in CVAS but retain access to the site in the event they would like to participate in the program in the future, also known as taking a break. They will not be required to complete any mandatory reporting during this time. This will enable the site to be able to participate in the Program again, should the need arise.
Log into the Vaccine Clinic Finder Connect and remove themselves as a vaccine provider from the Vaccine Clinic Finder.
If sites are in need of assistance when requesting either option via CVAS, you can contact the Vaccine Operations Centre (VOC) on 1800 318 208.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…